Tumor
metastasis and recurrence are recognized to be the main causes
of failure in cancer treatment. To address these issues, an “all
in one” and “one for all” nanoplatform was established
for combined “chemo–immuno–photothermal”
therapy with the expectation to improve the antitumor efficacy. Herein,
Docetaxel (DTX, a chemo-agent) and cynomorium songaricum polysaccharide
(CSP, an immunomodulator) were loaded into zein nanoparticles coated
by a green tea polyphenols/iron coordination complex (GTP/FeIII, a photothermal agent). From the result, the obtained nanoplatform
denoted as DTX-loaded Zein/CSP-GTP/FeIII NPs was spherical
in morphology with an average particle size of 274 nm, and achieved
pH-responsive drug release. Moreover, the nanoplatform exhibited excellent
photothermal effect both in vitro and in
vivo. It was also observed that the nanoparticles could be
effectively up take by tumor cells and inhibited their migration.
From the results of the in vivo experiment, this
nanoplatform could completely eliminate the primary tumors, prevent
tumor relapses on LLC (Lewis lung cancer) tumor models, and significantly
inhibit metastasis on 4T1 (murine breast cancer) tumor models. The
underlying mechanism was also explored. It was discovered that this
nanoplatform could induce a strong ICD effect and promote the release
of damage-associated molecular patterns (DAMPs) including CRT, ATP,
and HMGB1 by the dying tumor cells. And the CSP could assist the DAMPs
in inducing the maturation of dendritic cells (DCs) and facilitate
the intratumoral infiltration of T lymphocytes to clear up the residual
or disseminated tumor cells. In summary, this study demonstrated that
the DTX-loaded Zein/CSP-GTP/FeIII is a promising nanoplatform
to completely inhibit tumor metastasis and recurrence.